T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Pricesmart
PSMT
$5.49B
| $3.23M | ﹤0.01% |
45,160
+200
| +0.4% | +$15.5K |
|
1477
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $3.23M | ﹤0.01% |
+37,888
| New | +$3.43M |
|
1478
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.33B
| $3.22M | ﹤0.01% |
+35,506
| New | +$3.42M |
|
1479
Lennox International
LII
$14.5B
| $3.21M | ﹤0.01% |
15,538
-797,154
| -98% | -$174M |
|
1480
Valvoline
VVV
$4.25B
| $3.21M | ﹤0.01% |
111,309
-7,762
| -7% | -$238K |
|
1481
First Solar
FSLR
$24B
| $3.21M | ﹤0.01% |
47,052
+1,354
| +3% | +$96.4K |
|
1482
Relmada Therapeutics
RLMD
$507M
| $3.21M | ﹤0.01% |
168,757
+11,192
| +7% | +$244K |
|
1483
Oshkosh
OSK
$9.61B
| $3.18M | ﹤0.01% |
38,729
-4,408
| -10% | -$405K |
|
1484
Western Union
WU
$2.34B
| $3.17M | ﹤0.01% |
192,792
-2,539
| -1% | -$44.8K |
|
|
AXON
1485
Axon Enterprise
AXON
$48.7B
| $3.17M | ﹤0.01% |
34,071
-131
| -0.4% | -$13.9K |
|
|
MANT
1486
DELISTED
Mantech International Corp
MANT
| $3.15M | ﹤0.01% |
33,047
-130,081
| -80% | -$11.6M |
|
1487
EPR Properties
EPR
$4.7B
| $3.15M | ﹤0.01% |
67,121
-658
| -1% | -$33.3K |
|
|
CLR
1488
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $3.14M | ﹤0.01% |
48,020
+2,073
| +5% | +$131K |
|
1489
Dropbox
DBX
$7.31B
| $3.13M | ﹤0.01% |
149,067
-2,018
| -1% | -$43.7K |
|
1490
Lithia Motors
LAD
$8.32B
| $3.09M | ﹤0.01% |
11,228
+10
| +0.1% | +$2.92K |
|
1491
H&R Block
HRB
$6.87B
| $3.08M | ﹤0.01% |
87,330
-530
| -0.6% | -$16.4K |
|
1492
Woodside Energy
WDS
$43.6B
| $3.07M | ﹤0.01% |
+142,378
| New | +$3.23M |
|
1493
Chemours
CC
$2.29B
| $3.06M | ﹤0.01% |
95,453
-1,816
| -2% | -$66.8K |
|
|
WHWK
1494
Whitehawk Therapeutics
WHWK
$269M
| $3.05M | ﹤0.01% |
247,238
-188,713
| -43% | -$2.8M |
|
1495
Madrigal Pharmaceuticals
MDGL
$12.4B
| $3.04M | ﹤0.01% |
42,402
-2,497
| -6% | -$184K |
|
1496
Murphy Oil
MUR
$4.99B
| $3.02M | ﹤0.01% |
100,182
-8,053
| -7% | -$310K |
|
1497
Americold
COLD
$4.17B
| $3.01M | ﹤0.01% |
100,168
+12,618
| +14% | +$351K |
|
1498
iShares Russell 1000 ETF
IWB
$50.5B
| $3.01M | ﹤0.01% |
14,475
+339
| +2% | +$76.6K |
|
1499
HealthEquity
HQY
$8.83B
| $2.99M | ﹤0.01% |
48,723
+4,111
| +9% | +$263K |
|
1500
AutoNation
AN
$6.9B
| $2.97M | ﹤0.01% |
26,579
+279
| +1% | +$31.6K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.